bacteriology

🦠 Bacteriology · Core Concepts

Comprehensive notes for USMLE Step 1 · high‑yield & clinically integrated

🔬 Gram‑positive rods

Listeria monocytogenes

  • 🔬 Features
    Small β‑hemolytic rod, tumbling motility, facultative intracellular, grows at 4°C.
  • 🧬 Pathogenesis
    Listeriolysin O (pore‑forming) enables escape from phagosome; actin‑based motility spreads cell‑to‑cell.
  • ⚠️ Risks
    Pregnant women, neonates, elderly, immunocompromised (renal transplant, lymphoma).
  • Clinical: Amniotic infection → granulomatosis infantiseptica (early); late‑onset meningitis (2–3 weeks). In adults: febrile gastroenteritis or meningitis.
  • Diagnosis: Culture on blood agar; cold enrichment; CSF shows lymphocytic predominance with some PMNs.
  • Treatment: Ampicillin ± gentamicin (for severe/immunocompromised).
📌 High‑yield: Third most common cause of neonatal meningitis. Avoid deli meats & soft cheese in pregnancy.

Corynebacterium diphtheriae

  • Morphology: Club‑shaped, pleomorphic gram‑positive rods, metachromatic granules (volutin).
  • Toxin: Encoded by β‑prophage; ADP‑ribosylates eEF‑2 → inhibits protein synthesis.
  • Disease: Gray pseudomembrane (pharynx/tonsils), “bull neck”, myocarditis, polyneuritis.
  • Diagnosis: Elek test (immunoprecipitation) or PCR for tox gene.
  • Treatment: Antitoxin + erythromycin/penicillin. Prevention: DTaP/Tdap vaccine.
🧪 Pearl: Toxin production requires lysogeny; non‑toxigenic strains can be converted by phage.

Actinomyces israelii

  • Anaerobic, branching gram‑positive rods, non‑acid‑fast.
  • Normal flora of gingiva & female genital tract; endogenous infection.
  • Actinomycosis: chronic, indolent, cross‑tissue planes; “sulfur granules” in pus.
  • Forms: Cervicofacial (“lumpy jaw”), thoracic, abdominal, pelvic (IUD), CNS abscess.
  • Treatment: Penicillin G + surgical drainage; metronidazole NOT effective.

Nocardia asteroides & N. brasiliensis

  • Aerobic, branching, partially acid‑fast (weak) gram‑positive rods.
  • Soil saprophyte; inhalation or traumatic implantation.
  • Pulmonary: cavitary pneumonia in immunocompromised; hematogenous spread → brain abscess.
  • Cutaneous: mycetoma or cellulitis (N. brasiliensis).
  • Treatment: High‑dose sulfonamides or TMP‑SMX.
📌 High‑yield: Differentiate from Actinomyces: Nocardia is aerobic, partially acid‑fast, and sulfonamide‑sensitive.

🧫 Gram‑negative cocci

Neisseria meningitidis

  • Features: Kidney‑bean diplococci, oxidase (+), grows on chocolate agar, ferments maltose.
  • Capsule: 5 serogroups (A, B, C, Y, W‑135); B is poorly immunogenic (sialic acid).
  • Virulence: LPS endotoxin, IgA protease, pili.
  • Disease: Meningitis (abrupt, petechial rash), meningococcemia, Waterhouse‑Friderichsen (adrenal hemorrhage).
  • Treatment: Ceftriaxone/cefotaxime; prophylaxis for contacts: rifampin/ciprofloxacin.
🧪 Pearl: Complement deficiency (C5–C9) predisposes to Neisseria bacteremia.

Neisseria gonorrhoeae

  • Oxidase (+), glucose fermenter, maltose (−).
  • Pathogenesis: Pili (antigenic variation), Opa proteins, IgA protease.
  • Disease: Urethritis/cervicitis, PID, neonatal ophthalmia, disseminated arthritis/dermatitis.
  • Diagnosis: Gram‑negative diplococci intracellular in PMNs; culture on Thayer‑Martin.
  • Treatment: Ceftriaxone + azithromycin (co‑treatment for Chlamydia).
📌 High‑yield: No vaccine; β‑lactamase plasmid‑mediated resistance common.

Moraxella catarrhalis

  • Gram‑negative diplococcus, oxidase (+), normal upper respiratory flora.
  • Disease: Otitis media in children, COPD exacerbations in elderly.
  • Treatment: Amoxicillin‑clavulanate, TMP‑SMX, or cephalosporins (most strains produce β‑lactamase).

🧪 Gram‑negative bacilli (non‑Enterobacteriaceae)

Pseudomonas aeruginosa

  • Features: Oxidase (+), aerobic, non‑fermenter, blue‑green pigment (pyocyanin), grape‑like odor.
  • Pathogenesis: Exotoxin A (ADP‑ribosylation of eEF‑2), biofilm, LPS.
  • Disease: Burn wound infection, pneumonia (CF, CGD), UTI (catheter), otitis externa, ecthyma gangrenosum.
  • Treatment: Anti‑pseudomonal β‑lactam (ceftazidime, piperacillin‑tazobactam) + aminoglycoside or fluoroquinolone.
📌 High‑yield: Intrinsic resistance due to porin loss & efflux pumps; always check susceptibilities.

Legionella pneumophila

  • Gram‑negative (stains poorly), requires iron & cysteine (BCYE agar), facultative intracellular.
  • Reservoir: Water (cooling towers, plumbing); aerosol transmission.
  • Disease: Legionnaires’ (atypical pneumonia, hyponatremia, diarrhea, confusion) and Pontiac fever (mild).
  • Diagnosis: Urinary antigen (serogroup 1), DFA, or PCR.
  • Treatment: Azithromycin or levofloxacin ± rifampin.

Bordetella pertussis

  • Small gram‑negative coccobacilli, strict aerobe.
  • Virulence: Pertussis toxin (ADP‑ribosylates Gi), filamentous hemagglutinin, adenylate cyclase toxin.
  • Stages: Catarrhal → paroxysmal (whoop) → convalescent.
  • Diagnosis: Culture (Regan‑Lowe), PCR, DFA.
  • Treatment: Macrolide (erythromycin/azithromycin), supportive care.
🧪 Pearl: Vaccine (DTaP) immunity wanes after 5–10 years; adults are a reservoir.

Haemophilus influenzae

  • Features: Encapsulated (type b = polyribitol phosphate), requires X (hemin) & V (NAD) factors.
  • Satellite phenomenon: grows around Staphylococcus aureus on blood agar.
  • Disease: Meningitis (children 3 mo–2 y), epiglottitis, pneumonia, otitis media (non‑typeable).
  • Treatment: Ceftriaxone/cefotaxime; prophylaxis with rifampin for close contacts.
📌 High‑yield: Hib conjugate vaccine (T‑cell‑dependent) has dramatically reduced disease.

🧬 Enterobacteriaceae

  • Key traits: Gram‑negative rods, facultative anaerobes, ferment glucose, oxidase (−), reduce nitrate.
  • Antigens: O (somatic), H (flagellar), K (capsular), Vi (Salmonella capsule).
  • Lactose fermentation: Colored on MacConkey (e.g., E. coli, Klebsiella) vs. non‑lactose (Salmonella, Shigella, Proteus).
GenusKey featuresDiseaseTreatment
E. coliLactose (+), indole (+); ETEC, EHEC, UPECUTI, diarrhea, neonatal meningitis, sepsisCephalosporins, fluoroquinolones
KlebsiellaLactose (+), mucoid, capsulePneumonia (currant‑jelly sputum), UTICarbapenems / extended‑spectrum cephalosporins
SalmonellaNon‑lactose, H₂S (+), motileEnterocolitis, typhoid fever (S. Typhi)Fluoroquinolones, ceftriaxone (typhoid)
ShigellaNon‑lactose, non‑motile, no H₂SInflammatory diarrhea, bacillary dysenteryAzithromycin, ciprofloxacin
ProteusSwarming, urease (+)UTI, stonesβ‑lactams, TMP‑SMX
YersiniaNon‑lactose, urease (+), psychrophilicEnterocolitis, plague (Y. pestis)Aminoglycosides, doxycycline
🧪 Pearl: Enterobacteriaceae are oxidase (−); this distinguishes them from Pseudomonas (oxidase +).

🐾 Zoonotic & atypical pathogens

Brucella

  • Small gram‑negative rods, facultative intracellular, zoonosis (cattle, goats, pigs).
  • Transmission: Unpasteurized dairy, contact with animals.
  • Disease: Undulant fever – septicemia, night sweats, arthralgias, hepatomegaly.
  • Treatment: Doxycycline + rifampin (6 weeks).

Francisella tularensis

  • Small gram‑negative coccobacillus, facultative intracellular, bioterrorism agent.
  • Reservoir: Rabbits, ticks; transmission by tick bite, skinning, aerosols.
  • Disease: Ulceroglandular, pneumonic, typhoidal.
  • Treatment: Streptomycin or gentamicin.

Campylobacter jejuni

  • Curved gram‑negative rod (“gull‑wing”), oxidase (+), microaerophilic, grows at 42°C.
  • Transmission: Poultry, raw milk; low infectious dose.
  • Disease: Acute inflammatory diarrhea (bloody), often self‑limiting.
  • Complications: Guillain‑Barré syndrome (molecular mimicry), reactive arthritis.
  • Treatment: Macrolide (erythromycin) if severe.

Helicobacter pylori

  • Spiral gram‑negative, microaerophilic, urease (+), oxidase (+).
  • Pathogenesis: Urease neutralizes acid, mucinase penetrates mucus; chronic gastritis.
  • Disease: Peptic ulcer disease, gastric adenocarcinoma, MALT lymphoma.
  • Diagnosis: Urea breath test, stool antigen, biopsy with silver/Giemsa.
  • Treatment: Triple therapy (PPI + amoxicillin + clarithromycin) or quadruple (PPI + bismuth + metronidazole + tetracycline).
📌 High‑yield: WHO class I carcinogen; associated with gastric cancer and MALToma.

🦷 Fastidious & HACEK group

Haemophilus ducreyi

  • Chancroid: painful, soft genital ulcer (“painful vs. syphilis’ hard chancre”).
  • Requires hemin (X factor) for growth, DNA probe or “school‑of‑fish” on Gram stain.
  • Treatment: Azithromycin, ceftriaxone, or ciprofloxacin.

HACEK organisms

  • Haemophilus (Aggregatibacter), Aggregatibacter, Cardiobacterium, Eikenella, Kingella.
  • Normal oral flora; cause ~5‑10% of subacute infective endocarditis.
  • Treatment: Third‑generation cephalosporin or fluoroquinolone.

Pasteurella multocida

  • Small gram‑negative rod, animal bite (especially cat) → rapidly spreading cellulitis/lymphadenitis.
  • Treatment: Amoxicillin‑clavulanate (prophylaxis for cat bites).

🧫 Mycobacteria

Mycobacterium tuberculosis

  • Acid‑fast, aerobic, slow‑growing (Lowenstein‑Jensen), niacin (+), catalase (heat‑labile).
  • Pathogenesis: Sulfatides inhibit phagolysosome fusion; cord factor (trehalose dimycolate) contributes to virulence.
  • Primary TB: Ghon focus → Ghon complex; latent in granulomas.
  • Reactivation: Upper lobe cavitary disease, hemoptysis, night sweats, weight loss.
  • Diagnosis: Acid‑fast smear, culture, Quantiferon‑TB (interferon‑γ release), PPD (induration interpretation).
  • Treatment: RIPE (rifampin, isoniazid, pyrazinamide, ethambutol) for 2 months, then rifampin + isoniazid for 4 months. MDR TB: add aminoglycosides, fluoroquinolones, bedaquiline.
📌 High‑yield: PPD ≥5 mm in HIV+; ≥10 mm in high‑risk; ≥15 mm in low‑risk. BCG not used in U.S.

MOTT (Non‑tuberculous mycobacteria)

SpeciesDiseaseTreatment
M. avium complex (MAC)Disseminated in AIDS (CD4 <50), pulmonaryMacrolide + ethambutol
M. kansasiiPulmonary (chronic lung disease)Rifampin + ethambutol + isoniazid
M. marinum“Fish tank granuloma” (skin)Minocycline / clarithromycin
M. ulceransBuruli ulcer (Africa)Rifampin + streptomycin

Mycobacterium leprae

  • Obligate intracellular, cannot be cultured, grows at cooler temperatures.
  • Transmission: Nasal droplets; armadillos in southern U.S.
  • Forms: Tuberculoid (strong CMI, few lesions, nerve damage) vs. Lepromatous (weak CMI, numerous lesions, leonine facies).
  • Diagnosis: Punch biopsy / nasal scrapings, acid‑fast stain; lepromin test positive in tuberculoid, negative in lepromatous.
  • Treatment: Dapsone + rifampin; add clofazimine for lepromatous.

🌀 Vibrio & other important genera

Vibrio cholerae

  • Curved gram‑negative rod, oxidase (+), grows on alkaline media (TCBS).
  • Cholera toxin: ADP‑ribosylates Gs → persistent cAMP → massive watery diarrhea (“rice‑water”).
  • Treatment: Fluid/electrolyte replacement; doxycycline or azithromycin.
📌 High‑yield: Requires high inoculum if gastric acid normal; vaccine available (killed oral).

Vibrio vulnificus & V. parahaemolyticus

  • V. vulnificus: Seafood (oysters), brackish water; causes severe cellulitis/necrotizing fasciitis, especially in liver disease.
  • V. parahaemolyticus: Gastroenteritis from raw seafood; self‑limited.

Other key organisms

  • Burkholderia cepacia: Cystic fibrosis, CGD; TMP‑SMX treatment.
  • Acinetobacter baumannii: “Iraqibacter”; wound infections, highly drug‑resistant (carbapenem, polymyxin).
  • Eikenella corrodens: Human bite infections; bleach‑like odor; treat with 3rd‑gen cephalosporins.
  • Capnocytophaga canimorsus: Dog bite; asplenic patients → fulminant sepsis.
  • Bartonella henselae: Cat scratch disease (azithromycin), bacillary angiomatosis in AIDS.

Quick comparison · high‑yield features

OrganismKey distinctive featureTreatment
ListeriaCold growth, tumbling motility, intracellularAmpicillin ± gentamicin
C. diphtheriaeADP‑ribosylates eEF‑2, pseudomembraneAntitoxin + erythromycin
NocardiaPartially acid‑fast, aerobic branchingTMP‑SMX
PseudomonasOxidase (+), pyocyanin, biofilmAnti‑pseudomonal β‑lactam + AG
LegionellaBCYE agar, intracellular, hyponatremiaAzithromycin / levofloxacin
B. pertussisPertussis toxin (Gi ADP‑ribosylation), whoopMacrolide
H. influenzaeX & V factors, satellite growthCeftriaxone
TBAcid‑fast, niacin (+), catalase (−) at 68°CRIPE
💡 Clinical pearl: Always consider epidemiologic clues (animal exposure, travel, occupation, immunosuppression) when approaching gram‑negative or atypical infections.